Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT04943913
What this trial is testing

Study of GC101 TIL in Brain Glioma (Soochow2)

Who this might be right for
Glioma
Shanghai Juncell Therapeutics 50
Testing effectiveness (Phase 2)Study completedNCT01380782
What this trial is testing

BIBF 1120 for Recurrent High-Grade Gliomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
Patrick Y. Wen, MD 37
Testing effectiveness (Phase 2)Study completedNCT00462423
What this trial is testing

Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study

Who this might be right for
Metastatic Malignant Melanoma
Lynn E. Spitler, MD 50
Testing effectiveness (Phase 2)Study completedNCT00276679
What this trial is testing

Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Not applicableLooking for participantsNCT07567196
What this trial is testing

PET-Guided Resection in High-Grade Gliomas

Who this might be right for
Glioma Glioblastoma MultiformeGlioma, High GradeGlioma Surgery+1 more
Universita degli Studi di Genova 100
Not applicableStudy completedNCT06189261
What this trial is testing

Holistic Needs Assessments in Patients With Melanoma

Who this might be right for
MelanomaUnsatisfied Needs
University of Surrey 30
Not applicableUnknownNCT02327442
What this trial is testing

68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients

Who this might be right for
GliomaBreast Cancer
Xijing Hospital 46
Not applicableActive Not RecruitingNCT07475390
What this trial is testing

99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging

Who this might be right for
Glioma (Any Grade) in the Brain
Tomsk National Research Medical Center of the Russian Academy of Sciences 40
Testing effectiveness (Phase 2)Study completedNCT01266603
What this trial is testing

High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 44
Not applicableUnknownNCT04485442
What this trial is testing

Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face

Who this might be right for
Skin Cancer
University Hospital, Basel, Switzerland 100
Not applicableEnrolling By InvitationNCT05212103
What this trial is testing

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

Who this might be right for
Acute Myeloid LeukemiaMelanomaNon Small Cell Lung Cancer
Turku University Hospital 30
Not applicableLooking for participantsNCT05474573
What this trial is testing

Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases

Who this might be right for
Glioma, MalignantMetastases to Brain
Sklifosovsky Institute of Emergency Care 52
Early research (Phase 1)Ended earlyNCT02097225
What this trial is testing

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Not Yet RecruitingNCT07739017
What this trial is testing

OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma

Who this might be right for
Recurrent GlioblastomaNewly Diagnosed MGMT Unmethylated Glioblastoma
Olivia Newton-John Cancer Research Institute 54
Very early researchEnded earlyNCT03927274
What this trial is testing

Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma

Who this might be right for
Glioma of Brain
H. Lee Moffitt Cancer Center and Research Institute 3
Not applicableStudy completedNCT00618813
What this trial is testing

Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

Who this might be right for
Ewing Sarcoma of BoneLocalized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Children's Oncology Group 35
Early research (Phase 1)Study completedNCT00356460
What this trial is testing

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Who this might be right for
Carcinoma, Renal CellMelanoma
Genzyme, a Sanofi Company 29
Early research (Phase 1)Study completedNCT04082962
What this trial is testing

Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

Who this might be right for
Exudative Retinal Detachment and Uveal Melanoma
Ivana K. Kim 10
Early research (Phase 1)Active Not RecruitingNCT03478462
What this trial is testing

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Who this might be right for
Pediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more
Cellectar Biosciences, Inc. 30
Not applicableLooking for participantsNCT06090903
What this trial is testing

Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma

Who this might be right for
GlioblastomaRecurrent GlioblastomaResectable Glioblastoma
Jonsson Comprehensive Cancer Center 50
Next Page